Business Wire (Free subscription) | 09/10/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) today announced that patients with schizophrenia now have a new administration option for RISPERDAL
Business Wire (Free subscription) | 08/10/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) today announced the election of David Anstice to the company’s Board of Directors. Mr.
Business Wire (Free subscription) | 16/09/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by UBS on Tuesday, September 23, 2008 at 12:30 p.m. EDT.
The Street (Free subscription) | 16/09/2008
Alkermes, BP, TAL International Group, Terex and MEMC Electronic Materials downgraded.
Red Orbit (Free subscription) | 03/09/2008
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Morgan Stanley on Tuesday, September 9, 2008 at 9:45 a.m. EDT and by Robert W. Baird on Wednesday, September 10, 2008 at 12:40 p.m. EDT.
Business Wire (Free subscription) | 02/09/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Morgan Stanley on Tuesday, September 9, 2008 at 9:45
Business Wire (Free subscription) | 29/08/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008
Market Watch (Free subscription) | 28/08/2008
Drug stocks gain in early action Thursday as shares of Amylin Pharmaceuticals rise after being pummeled Wednesday by negative news about its diabetes drug Byetta.
The Street (Free subscription) | 22/08/2008
PepsiAmericas, Alkermes, American Medical Systems Holdings and Myriad Genetics upgraded; Akamai Technologies downgraded.
Allergic Info (Free subscription) | 16/08/2008
Exenatide once weekly use a proprietary technology for long-acting medication s, commerce by Alkermes. The technology encapsulates stay alive medication into polymer-based microspheres that be inject into the body, where on floor they lower slowly but undoubtedly, at a snail`s pace unbind the linctus in a controlled attitude to furnish continuous reviving exenatide levels in plasma. "The promise anti...
The Street (Free subscription) | 13/08/2008
Alcohol dependence drug naltrexone has caused adverse reactions at injection sites for some patients.
Boston Globe (Free subscription) | 12/08/2008
Federal regulators warned doctors Tuesday about severe skin reactions seen in patients taking an injectable treatment for alcoholism made by Alkermes Inc. and marketed by Cephalon Inc.
Health - The Post Chronicle (Free subscription) | 12/08/2008
Nearly 200 patients given Alkermes Inc's drug Vivitrol for alcohol dependence reported complications from the injection,......
The Philadelphia Business Journal (Free subscription) | 12/08/2008
A drug to treat alcoholism developed by Alkermes Inc. has caused blood clots, swelling, abscesses, cell death and other adverse reactions in nearly 200 cases, according to a warning for health-care professionals issued Tuesday by the Food and Drug Administration. (ALKS) (CEPH)
The Boston Business Journal (Free subscription) | 12/08/2008
A drug to treat alcoholism developed by Alkermes Inc. has caused blood clots, swelling, abscesses, cell death and other adverse reactions in nearly 200 cases, according to a warning for health care professionals issued Tuesday by the U.S. Food and Drug Administration.
